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We have significantly improved hospital mortality from sepsis and critical illness in last 10 years; however,
over this same period we have tripled the number of ‘ICU survivors’ going to rehabilitation. Furthermore, as
up to half the deaths in the first year following ICU admission occur post-ICU discharge, it is unclear how
many of these patients ever returned home or a meaningful quality of life. For those who do survive, recent
data reveals many ‘ICU survivors’ will suffer significant functional impairment or post-ICU syndrome (PICS).
Thus, new innovative metabolic and exercise interventions to address PICS are urgently needed. These
should focus on optimal nutrition and lean body mass (LBM) assessment, targeted nutrition delivery,
anabolic/anticatabolic strategies, and utilization of personalized exercise intervention techniques, such as
utilized by elite athletes to optimize preparation and recovery from critical care.
Recent findings
New data for novel LBM analysis technique such as computerized tomography scan and ultrasound
analysis of LBM are available showing objective measures of LBM now becoming more practical for
predicting metabolic reserve and effectiveness of nutrition/exercise interventions. 13C-Breath testing is a
novel technique under study to predict infection earlier and predict over-feeding and under-feeding to target
nutrition delivery. New technologies utilized routinely by athletes such as muscle glycogen ultrasound also
show promise. Finally, the role of personalized cardiopulmonary exercise testing to target preoperative
exercise optimization and post-ICU recovery are becoming reality.
Summary
New innovative techniques are demonstrating promise to target recovery from PICS utilizing a combination
of objective LBM and metabolic assessment, targeted nutrition interventions, personalized exercise
interventions for prehabilitation and post-ICU recovery. These interventions should provide hope that we will
soon begin to create more ‘survivors’ and fewer victim’s post-ICU care.
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In-hospital mortality following severe sepsis has
consistently declined in recent years [1]. However,
the same data also reveal that many of these patients
are not returning home to functional lives post-ICU,
but instead to rehabilitation settings where it is
unclear whether they ever returned to a meaningful
quality of life (QoL). In fact, in the same period that
in-hospital ICU mortality appears to be declining
appears we have tripled the number of patients
going to rehabilitation settings [1]. We also know
that up to 40% of mortality within the first year of
ICU stay occurs following ICU discharge [2].
Unfortunately for those who do survive, nearly half
of the survivors will not return to work in the firstht © 2017 Wolters Kluwer Health, Inc. All rights reserved.
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KEY POINTS
 We have significantly improved in-hospital mortality
from sepsis and critical illness in last 10 years;
however, due to PICS over this same period we have
tripled the number of ‘ICU survivors’ going to
rehabilitation where it is unclear whether they ever
return to a meaningful QoL.
 New innovative techniques are demonstrating promise
to target recovery from PICS utilizing a combination of
objective LBM and metabolic assessment, targeted
nutrition interventions, personalized exercise
interventions for prehabilitation, and post-ICU recovery.
 Admission skeletal muscle mass and quality via CT scan
are predictive of mortality and complications following
surgery and critical care and may prove useful to
predict preillness metabolic reserve and patients in
need of preillness nutritional optimization.
 Novel technique such as 13C-breath testing to assess
over-feeding/under-feeding and muscle glycogen to
evaluate muscle recovery and transition to ‘recovery
phase’ are showing promise as objective methods to
personalize nutrition and recovery interventions.
 CPET is being utilized to predict operative risk and
personalize preoperative (prehabilitative) exercise
interventions, with promise to guide post-ICU exercise
interventions for PICS.
Metabolic supportyear postdischarge [3
&&
], often due to postintensive
care syndrome (PICS) and weakness post-ICU [4
&
].
As a result, many leading experts are calling for
future ICU trials to not focus on mortality as the
primary endpoint, but rather to focus on QoL [5
&&
],
physical function, and addressing the epidemic of
PICS [1,6].
Specific to lean body mass (LBM) in the ICU, we
know a critically ill burn patient can lose as much as
a kilogram of LBM a day [7
&
]. Other critically ill
patients also suffer significant LBM loss, much of
it in the first 7–10 days of ICU stay [8
&&
]. Patients will
gain weight back following ICU stay, but virtually all
this weight is fat mass, not functional LBM [9]. This
is not surprising, as data from the burn ICU dem-
onstrates the catabolic/hypermetabolic state follow-
ing injury can persist for up to 2 years following
discharge from hospital, and this can markedly
hinder recovery of patients LBM and function fol-
lowing injury [7
&
]. As will be discussed in this review,
we desperately need objective methods of screening
and quantifying a patient’s metabolic, exercise, and
LBM reserve prior to anticipated injury/illness (such
as surgery/cancer therapy). These should serve as
key predictors of preoperative/preillness risk and
screen for patients in need of ‘prehabilitation’ prior Copyright © 2017 Wolters Kluwer 
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describe, interventions such as computerized tom-
ography (CT) scan LBM analysis and cardiopulmo-
nary exercise testing (CPET) are already being
utilized and studied around the world to assess
preoperative ‘metabolic reserve’ and ‘fitness for
surgery’. These should be complemented by objec-
tive measures of patient’s nutritional needs during
illness and recovery. Further the effect of nutrition
delivery on muscle uptake of nutrients and muscle
‘fitness’ for exercise interventions may be a reality in
our ICU’s soon [8
&&
,10
&
]. Finally, we must improve
our post-ICU care ‘recovery’ care and take respon-
sibility for the deficits in strength, function, and
cognition we create in our ICU care. We owe it to our
ICU patients to continue to use new innovations in
objective nutrition delivery to guide nutrition and
personalized exercise interventions to guide func-
tional recovery.ANALYSIS OF LEAN BODY MASS AND
RELATIONSHIP TO SURGICAL AND ICU
OUTCOME
Baseline skeletal muscle mass [11] and quality [12
&&
]
are demonstrated to be predictive of mortality in
ICU patients. Muscle wasting and weakness are also
major contributors to PICS [4
&
,13
&
]. This is not
unsurprising, as these parameters reflect ‘metabolic
reserve’, which is effected by physical activity,
nutrition, chronic disease and is tightly linked to
function [3
&&
]. In surgical patients, a rapidly grow-
ing body of literature demonstrates low baseline
skeletal muscle mass may be an independent risk
factor for surgical complications in patients under-
going hepatic [14
&
] colorectal [15
&
,16
&
], diverticular
[17
&
], and pancreatic [18
&
] oncological surgery.
Muscle mass loss prepost oncological surgery (just
as with ICU patients [19]) is an additional risk factor
for complications [20
&
] and mortality [21
&&
,22
&
].
Low muscle contributes to increased length of stay
in cardiac surgery [23
&
] and in patients undergoing
transcatheter aortic valve replacement (TAVR)
[24
&
].
A major limitation of these studies is their retro-
spective nature. First, we are unable to exclude type
II errors: in contrast to the studies above no com-
plications were seen in a patient cohort undergoing
endometrial cancer resection [25] and ovarian
surgery [26
&
]. Although low muscle mass was associ-
ated with mortality in gastric cancer, no association
was seen with complications [27
&
]. Secondly, we are
therefore unable to dissect differences between
positive and negative studies, that is, in which
surgical procedures does low skeletal muscle mass
pose an additional risk for complications?Health, Inc. All rights reserved.
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MUSCLE MASS
Although the evidence from observational studies of
baseline muscle mass and quality continues to grow,
sufficient data to justify intervention development
exists. Primary outcomes should be focused on func-
tion and/or complications as opposed to mortality.
Performing a baseline muscle mass assessment
in the acutely critically ill patient is challenging.
Transfer for CT scans is not without risk and may be
ethically difficult to justify and lead to selection
bias. Muscle ultrasound is an attractive emerging
technique and is also able to offer qualitative
analysis [28
&
]. Ultrasound is inexpensive and readily
available. Bedside measurements of muscle mass are
possible with existing routine ICU ultrasound
equipment. Unlike CT however, international con-
sensus does not exist on methodology, with signifi-
cant differences between techniques [29
&&
].
To advance this science, studying the high-risk
surgical patient has two major advantages. First, if
the complication and return to work rates can be
altered, there are significant gains to be attained for
the patient, healthcare providers, and society.
Secondly methodological difficulties are minimized
regarding consent, obtaining muscle mass measure-
ments preinsult and determining preexisting func-
tional outcome. A recent prospective observational
study demonstrated the ability of preoperative CT
assessment of muscle quality in predicting surgical
complications [21
&&
]. In designing interventional
trials, caution will be needed with regard to data
analysis planning and power calculations. Muscle
mass must be considered one of a group of stratifi-
cation variables in a multidimensional fashion [30
&
],
much like the ICU Nutritional Risk Score or
(NUTRIC) score [30
&
]. We have yet to understand
how interdependent muscle mass, muscle quality,
and functional disability are, and which and how we
should either stratify or correct for baseline differ-
ences [31
&&
].BEDSIDE ANALYSIS OF METABOLIC
STATE AND OVER-FEEDING/UNDER-
FEEDING: PROMISE OF NEW
TECHNOLOGY
The accurate determination of caloric needs and
objective measures of over-feeding/under-feeding
over time in critical care has long been a challenge
for ICU practitioners and a recent large observatio-
nal cohort has been conducted on this topic [32
&
].
Indirect calorimetry, despite its limitations in the
hospital setting, has been traditionally utilized for
estimating energy needs [32
&
]. The next evolution of
modern indirect calorimetry is described in this Copyright © 2017 Wolters Kluwe
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&
]. However, indirect
calorimetry has traditionally proven expensive,
has significant limitations in the ICU (i.e., cannot
be used on CVVH or with FiO2 > 60%), and is not
readily available.
To address this need for objective, bedside meta-
bolic monitoring, new technologies to measure
carbon-12 and carbon-13 (13CO2/
12CO2) ratios in
exhaled breath are showing promise to objectively
indicate type of metabolic fuel use and over-feeding/
under-feeding over time in an easy-to-use, noninva-
sive fashion. This technology is currently under
study to for applications related to early infection
detection and macronutrient use and caloric need
Fig. 1a and b) [34,35].
Carbon-12 and carbon-13 (12C,13C) are naturally
occurring isotopes that are found in exhaled breath.
Stable isotopes of carbon isotope exist naturally in
the body; however, the isotopic distribution of is not
uniform. Because of chemical and enzymatic dis-
crimination against the heavier 13C (i.e., fraction-
ation) in various steps in lipid synthesis body fats
are 3–10% depleted in 13C compared with body
proteins and carbohydrates (CHOs) [36,37
&
]. Based
on this isotopic difference between the primary
metabolic fuel sources, it is possible to determine
relative differences in metabolic fuel use at the
macronutrient level by measuring the isotopic ratio
of exhaled breath (Fig. 1a and b), which now is
possible in small ICU-based or bedside devices.
Similar to the respiratory exchange ratio that
measures rate of oxygen consumption and CO2
production in exhaled breath, the exhaled
13CO2/
12CO2 ratio is correlated to ratio of CHO/
protein:lipid oxidation [37
&
,38]. This technique
has been used in wild life ecology studies to deter-
mine metabolic fuel usage in birds during different
types of flight. For example, humming birds rely
primarily on CHO source during hovering flight
while migratory birds rely on stored lipids to power
long range flights over may thousands of kilometers
[39
&&
,40]. More recently, this technique has been
applied in humans to understand metabolic fuel
usage in health and disease. For example, exhaled
13CO2/
12CO2 was a biomarker for metabolic fuel
usage in women with polycystic ovarian syndrome
shown to have metabolic inflexibility in switching
from CHO to lipids during an overnight fast [34].
Similarly, healthy adults during intense exercise
(>50%VO2max) increased
13CO2/
12CO2 ratio post-
exercise indicting increased reliance on CHO for
energy [41]. In another study, adults on a healthy
weight loss diet (40% energy restriction) demon-
strated decreases in 13CO2/
12CO2 from prediet base-
line, indicating increased reliance on body lipids
[35]. Ongoing studies are examining the exhaledr Health, Inc. All rights reserved.
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(a)
(b)
FIGURE 1. (a) Multiple potential roles of 13C-carbon breath testing in ICU and hospitalized patient. (b) Hypothetical example
of readout from 13C-carbon breath testing and data that may be able to obtained by future clinicians in ICU. Adapted from
refs. [34,35]).
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12CO2 ratio for metabolic fuel usage in our
hospital/ICU setting at Duke University and at other
US centers for patients requiring total parenteral
nutrition (personal communication).METABOLIC RESPONSE TO ICU:
RELATIONSHIP TO EXERCISE STRESS
AND MEASUREMENT
The hypermetabolic response to physiological stress
weather at the ICU or running a marathon necessary
for cellular energy requirements elicits major alter-
ations in CHO metabolism, which in critically ill
patients can have an important impact on muscle
mass and survival. During exercise, CHOox
increases due to the higher rate for ATP synthesis
to satisfy muscle contractile demand [42] (Inigo San-
Millan and George Brooks, 2017, personal com-
munication) (Fig. 2) [42,43]. Surprisingly, a paucity
of information on CHOox rates in ICU patients
exists. It is believed though that CHOox can be
4–7 mg/kg/min [43], which is approximately two
to three times that of resting levels.
During both exercise and critical illness, CHOs
need to be mobilized in an orchestrated manner.
During exercise, glycogenolysis for glycolysis is pro-
vided from both the liver and from skeletal muscle
glycogen. Upon ceasing exercise, glycogen stores are
repleted via proper nutrition. However, metabolic
demand of ICU patients represents, overtime, the
most extreme metabolic demand observed in
humans. This demand is nonstopping, stretching
the limits of ‘human performance’. Humans are not
‘trained’ to be critically ill, which is challenging as
the body attempts to mobilize energy stores, driven
mainly by cortisol. Therefore, a second phase of
CHO metabolism relies on gluconeogenic precur-
sors from skeletal muscle proteolysis. Glycogen
depletion can elicit a significant increase in muscle Copyright © 2017 Wolters Kluwe
FIGURE 2. Carbohydrate (CHO) oxidation (mg/kg/min)
during rest, ICU and different exercise intensities. Adapted
from [42,43] and Inigo San-Millan and George Brooks,
2017, personal communication). Wmax, percentage of
maximal exercise work.
1070-5295 Copyright  2017 Wolters Kluwer Health, Inc. All rights reseprotein breakdown. During physiological stress
situations such as exercise, protein breakdown
accounts for 4% of total exercise caloric expendi-
ture under CHO loading. However, under glycogen
depletion, protein breakdown is significantly elev-
ated contributing to 10% of total caloric expendi-
ture [44]. During exercise post-CHO loading, protein
breakdown during exercise accounted for 5.8 versus
13.7 g/h when muscle glycogen was depleted
[44]. Undoubtedly, the repercussions of glycogen
depletion on skeletal muscle protein breakdown
and catabolism in ICU can be significant and
devastating.
New cutting-edge ultrasound technology [45] is
being utilized routinely by the world’s most elite
professional athletes (i.e., Tour de France) to directly
measure muscle glycogen in a few minutes at the
bedside [45]. This technology is utilized by athletes
to predict and prevent overtraining and guide nutri-
tional needs during training. Glycogen depletion
leads to marked muscle damage and an inability
for muscle to recover and become anabolic, as
muscle protein must be broken down for energy
when energy cannot be obtained from glycogen
stores. This leads to ongoing catabolism and
inability to recover muscle mass and function
[45]. We have previously shown muscle glycogen
stores are depleted in ICU patients [10
&
], even within
hours of admission (Figs 3 and 4) [10
&
]. In contrast,
even elite endurance athletes do not completely
deplete their glycogen stores after a major compe-
tition, such as prolonged bike racing or a marathon
(Figs 3 and 4). Thus, one might equate being in the
ICU as similar to continuously running multiple
marathons. It is hoped this ultrasound technique
[45] can open new doors in monitoring nutritional
and catabolic status in critically ill patients. Thisr Health, Inc. All rights reserved.
FIGURE 3. Muscle glycogen scores via ultrasound. Adapted
from ref. [10&].
rved. www.co-criticalcare.com 273
FIGURE 4. Skeletal muscle glycogen content score via
ultrasound. Adapted from ref. [10&].
Metabolic supporttechnology we hope can guide when patients
transition from the acute, catabolic phase of critical
illness to a chronic or recovery phase, where
increased nutrition delivery and potentially ana-
bolic agents are warranted.PERSONALIZING PREHABILITATIVE AND
POST-ICU EXERCISE INTERVENTIONS
Although clearly distinct from critical care, the peri-
operative setting provides interesting data on the
relationship between physical fitness and clinical
outcomes, along with some intriguing mechanistic
insights. This is relevant to critical care because
many patients undergoing elective major surgery
are subsequently admitted to ICU, electively or in
response to postoperative complications. Further-
more, patients undergoing major surgery have long
been considered a valuable model for critical illness:
many of the same pathophysiological processes
occur and reliable premorbid physiological data is
available – a rare luxury in the ICU.
The relationship between physical fitness and
clinical outcomes postoperatively has been known
for more than 20 years. This relationship demon-
strates a consistent association between higher
levels of activity and/or physical fitness in almost
every aspect of human health and disease. Much of
the perioperative literature utilizes cardiopulmo-
nary pulmonary exercise testing (CPET) to measure
preoperative ‘fitness’. The early seminal publi-
cations originated from Older et al. [46], but more
recently work in the UK has illuminated the field. A
recent systematic review [47
&&
] from 37 studies
including 7852 patients concluded CPET was a use-
ful preoperative risk-stratification tool able to Copyright © 2017 Wolters Kluwer 
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range of surgical specialties, but further research was
needed to justify ability of CPET to predict post-
operative outcome. Following this review, the first
multicenter perioperative CPET study [48
&&
] eval-
uated the relationship between CPET measurements
and in-hospital morbidity in 703 patients under-
going major elective colorectal surgery in six cen-
ters. Consistent with previous studies, both
anaerobic threshold and peak oxygen consumption
(VO2P) were predictive of postoperative morbidity
with area under the receiver operating characteristic
curve (AUROC) of 0.79 and 0.77, respectively. Multi-
variable logistic regression model showed low
anaerobic threshold and VO2P along with high
BMI and nonlaparoscopic techniques to be associ-
ated with increased odds of in-hospital morbidity. A
model comprising all these variables discriminated
well between patients with, and without, in-hospital
morbidity (AUROC 0.83).
Other approaches to evaluating physical fitness
before surgery that have been less well evaluated
including 6-min-walk tests and simple stair climb-
ing. Although all the indices of physical fitness
are correlated to each other, the strength of this
relationship is often surprisingly weak [49
&
] and it is
unclear whether alternative approaches will be as
effective at predicting adverse outcome as CPET,
the technology with the vast majority of data.
Data collection for the international multicenter
measuring exercise tolerance after surgery (METS)
study [50
&
] recently completed (target sample
size 1723 patients). METS will provide comparative
data on CPET, questionnaire-based activity assess-
ment (the Duke Activity Status Index), cardiac bio-
markers (NT-pro-BNP), and clinician judgment for
the prediction of perioperative risk and a compari-
son with 6-min walk testing in a substudy of
patients.
A recent development has been the observation
that presurgery cancer therapies, such as neoadju-
vant chemoradiotherapy and chemoradiotherapy,
may impact preoperative physical fitness and out-
come following surgery. A UK study demonstrated a
significant decrement in CPET-derived anaerobic
threshold and peak oxygen consumption in neo-
adjuvant chemotherapy (NAC) patients before elec-
tive upper gastrointestinal surgery [51
&&
]. Lower
baseline fitness associated with reduced 1-year-
survival in patients completing NAC and surgery,
but not in patients who did not complete NAC. A
follow-up study in elective colorectal cancer surgery
demonstrated a similar harmful effect on physical
fitness that was in turn associated with increased
morbidity in the least fit patients [52
&
]. Larger
studies are currently underway in this area.Health, Inc. All rights reserved.
Volume 23  Number 4  August 2017
FIGURE 5. Future of targeted metabolic, lean body mass,
exercise, and nutrition care in ICU. CPET, cardiopulmonary
exercise testing; GH, growth hormone; GLN, glutamine;
HMB, b-hydroxy b-methylbutyrate; LBM, lean body mass.
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surgery brought both the challenge of a reduction in
physical fitness, but also an opportunity due to the
period after therapy and before surgery typically
allowed for patients to recover from these often-
debilitating therapies. The result has been studies
evaluating effect of exercise interventions preoper-
atively in these patients, many of which are cur-
rently ongoing. An early blinded, nonrandomized,
trial [53] in elective colorectal surgery demonstrated
a 6-week structured in-hospital aerobic training pro-
gram could reverse the effect of neoadjuvant chemo-
radiotherapy and return patients to baseline fitness
levels. A systematic review of prehabilitation for
major intercavity surgery [54] concluded preopera-
tive aerobic exercise training interventions were
feasible, safe, and effective in improving physical
fitness, but limited evidence for improved clinical
outcomes.
At present, data are not available to provide
strong recommendations about clinical outcome
but several large (>1000 patients) studies are cur-
rently ongoing. Although improved cardiorespira-
tory fitness may be the most intuitively obvious
benefit of such training, early mechanistic studies
suggest that changes in mitochondrial physiology
also occur [55], and it may be these will be more
relevant if/when clinical outcome benefit. If this is
true, it raises the concept of mimicking benefits of
exercise by pharmacological means in patients who
cannot or will not exercise. Finally, the potential for
CPET techniques to be utilized in the ICU setting
and in the post-ICU recovery needs to be explored.CONCLUSION
The current call for personalizing ICU care is begin-
ning to be addressed in the metabolism and nutri-
tion delivery field [8
&&
] by early studies validating
the role of the NUTRIC score in nutrition risk pre-
diction [56
&
]. This data shows high-malnutrition
risk patients may benefit to a greater degree than
those with lower risk. The novel assessments, as
described in this review, may be key innovations
preoperatively and in facilitating post-ICU recovery.
Patients with low muscle quality and quantity via
CT scan may have greater and different specific
nutritional needs. Preoperative patients with low
LBM or poor skeletal muscle quality could be
enrolled in prehabilitative exercise/nutrition pro-
grams to improve skeletal muscle quality and
quantity [57
&&
]. Interventional trials evaluating
muscle quality and quantity measures via CT scan
and/or ultrasound will also need to be performed to
assess targeted methods to optimize patients.
Furthermore, in ICU, these techniques need Copyright © 2017 Wolters Kluwe
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effects of individual nutrition (e.g., protein delivery,
anabolic agents [10
&
]) and specific ICU-rehabilita-
tion (e.g., in-bed ergometry, functional electrical
muscle stimulation [58]) interventions. Current
functional testing (i.e., Medical Research Council
sum score, hand-grip strength, walk-testing) are
volitional and not muscle specific, and have signifi-
cant implementation, interpretation, and compli-
ance challenges [59]. Thus, the role of objective
measures of LBM, muscle, nutrition need and exer-
cise targeting measurement described here deserve
additional study and validation to add an additional
‘dimension’ to our prediction of outcome and per-
sonalization of care in the ICU [30
&
].
In conclusion, we must strive to not only con-
tinue to evolve technology and therapeutics
targeted at improving survival in the ICU, but at
the same time focus on innovations to improve our
delivery of nutrition, metabolic support, and exer-
cise interventions. These interventions should be
implemented throughout the continuity of care –
beginning in the ‘prehabilitation’ period (i.e., pre-
operatively or precancer therapy period), continue
in the hospital and ICU setting, and then intensify
in the post-ICU ‘recovery’ phase (Fig. 5).
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